Nuveen Asset Management, LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,245,836
-0.8%
141,585
-28.7%
0.00%0.0%
Q2 2023$3,272,325
+371333.0%
198,443
+301.7%
0.00%
Q1 2023$881
-36.3%
49,404
+4.0%
0.00%
-100.0%
Q4 2022$1,383
-99.9%
47,491
+17.9%
0.00%
Q3 2022$987,000
+477.2%
40,290
-2.2%
0.00%
Q2 2022$171,000
-92.4%
41,205
-79.4%
0.00%
-100.0%
Q1 2022$2,250,000
+11.4%
199,950
-1.2%
0.00%0.0%
Q4 2021$2,020,000
-27.7%
202,378
-5.4%
0.00%0.0%
Q3 2021$2,794,000
-43.0%
213,982
-14.5%
0.00%0.0%
Q2 2021$4,900,000
+50.3%
250,256
+63.3%
0.00%0.0%
Q1 2021$3,260,000
-18.8%
153,269
+13.4%
0.00%0.0%
Q4 2020$4,017,000
+54.9%
135,106
+12.9%
0.00%0.0%
Q3 2020$2,593,000
-1.3%
119,659
+1.6%
0.00%0.0%
Q2 2020$2,626,000
+61.9%
117,777
+10.5%
0.00%0.0%
Q1 2020$1,622,000
-29.2%
106,596
+6.9%
0.00%0.0%
Q4 2019$2,290,000
+43.9%
99,741
+35.3%
0.00%0.0%
Q3 2019$1,591,000
-6.3%
73,716
-4.5%
0.00%0.0%
Q2 2019$1,698,00077,1850.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,075,000$47,569,3755.56%
NEA Management Company, LLC 2,909,956$66,710,7415.15%
Opaleye Management Inc. 653,000$14,970,0254.87%
Frazier Life Sciences Management, L.P. 2,371,304$54,362,1443.61%
VR Adviser, LLC 1,090,000$24,988,2502.63%
RA Capital Management 5,676,067$130,123,8362.56%
Samsara BioCapital, LLC 345,293$7,915,8422.42%
SILVERARC CAPITAL MANAGEMENT, LLC 260,537$5,972,8111.81%
Logos Global Management LP 400,000$9,170,0001.22%
Cormorant Asset Management, LP 850,000$19,486,2501.14%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders